INTERCEPT PHARMACEUTICALS
Summary
Intercept Pharmaceuticals is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases.
Deals Overview
Total Deals2
Valued Deals2
Total Value£ 1.01 B
Avg. Deal Size£ 504 M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
